BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 12417862)

  • 41. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
    Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Morphological diagnosis and classification of lung tumors].
    Kraft R
    Ther Umsch; 1994 Apr; 51(4):231-7. PubMed ID: 8191386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New WHO-classification of lung and pleural tumors].
    Wagenaar SS
    Ned Tijdschr Geneeskd; 1999 May; 143(19):984-90. PubMed ID: 10368718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases.
    Nakajima M; Kasai T; Hashimoto H; Iwata Y; Manabe H
    Cancer; 1999 Aug; 86(4):608-16. PubMed ID: 10440688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression of neural-cadherin in pulmonary epithelial tumours.
    Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
    Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
    Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New data in the classification of pulmonary neuroendocrine proliferation].
    Lantuejoul S; Brambilla E
    Ann Pathol; 2000; 20 Suppl():S131-4. PubMed ID: 11261291
    [No Abstract]   [Full Text] [Related]  

  • 48. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability.
    den Bakker MA; Willemsen S; Grünberg K; Noorduijn LA; van Oosterhout MF; van Suylen RJ; Timens W; Vrugt B; Wiersma-van Tilburg A; Thunnissen FB
    Histopathology; 2010 Feb; 56(3):356-63. PubMed ID: 20459535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
    Faggiano A; Sabourin JC; Ducreux M; Lumbroso J; Duvillard P; Leboulleux S; Dromain C; Colao A; Schlumberger M; Baudin E
    Cancer; 2007 Jul; 110(2):265-74. PubMed ID: 17569104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Histological typing of lung tumors. Second edition, 1981 (author's transl)].
    Ann Pathol; 1981; 1(3):177-91. PubMed ID: 7306379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Broncho-pulmonary adenocarcinoma].
    Piard F; Camus P
    Ann Pathol; 1993; 13(6):390-404. PubMed ID: 8141932
    [No Abstract]   [Full Text] [Related]  

  • 53. [Classification and pathogenesis of lung carcinoma].
    Brambilla E; Lantuejoul S; Sturm N
    Rev Prat; 2003 Apr; 53(7):714-20. PubMed ID: 12879793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroendocrine structures in normal and diseased human lung.
    Mosca L; Ceresoli A; Anzanello E; Mauri F; Mariscotti C; Timossi R; Barbareschi M; Mezzetti M
    Appl Pathol; 1986; 4(3):147-61. PubMed ID: 3036186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity.
    Iyoda A; Hiroshima K; Moriya Y; Mizobuchi T; Otsuji M; Sekine Y; Shibuya K; Iizasa T; Saitoh Y; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1891-5; discussion 1895. PubMed ID: 15172230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Personal experience in surgical management of pulmonary pleomorphic carcinoma.
    Raveglia F; Mezzetti M; Panigalli T; Furia S; Giuliani L; Conforti S; Meda S
    Ann Thorac Surg; 2004 Nov; 78(5):1742-7. PubMed ID: 15511465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined large cell neuroendocrine carcinoma and spindle cell carcinoma of the lung.
    Khalifa M; Hruby G; Ehrlich L; Danjoux C; Perez-Ordoñez B
    Ann Diagn Pathol; 2001 Aug; 5(4):240-5. PubMed ID: 11510007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary carcinoid and related tumours.
    Hasleton PS; Bostanci G
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lung neoplasms: problems of histologic classification and metastasing].
    Uehlinger E
    Thoraxchir Vask Chir; 1971 Aug; 19(4):237-44. PubMed ID: 5284957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.